(Q37792249)

English

The 2009 US Preventive Services Task Force (USPSTF) Guidelines are not Supported by Science: The Scientific Support for Mammography Screening

scientific article published on September 1, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

The 2009 US Preventive Services Task Force (USPSTF) guidelines are not supported by science: the scientific support for mammography screening (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

The 2009 US Preventive Services Task Force (USPSTF) Guidelines are not Supported by Science: The Scientific Support for Mammography Screening (English)

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

1 reference

based on heuristic

inferred from title

health planning guidelines

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20868889

19 July 2024

author name string

Daniel B. Kopans

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20868889

19 July 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20868889

19 July 2024

publication date

1 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0033838910000862?httpAccept=text/xml

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

https://api.elsevier.com/content/article/PII:S0033838910000862?httpAccept=text/plain

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Radiologic Clinics of North America

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

843-857

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Evaluation of the increase in breast cancer incidence in relation to mammography use.

1

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality

2

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Effect of screening and adjuvant therapy on mortality from breast cancer

3

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality

4

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties

5

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review

6

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Estimation of currently attainable benefit from mammographic screening of women aged 40-49 years

7

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Breast Cancer Detection Demonstration Project: five-year summary report

9

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

The mammographic screening trials: commentary on the recent work by Olsen and Gøtzsche

10

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Screening for “Cancer”: When is it Valid?—Lessons from the Mammography Experience

11

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Periodic Breast Cancer Screening in Reducing Mortality From Breast Cancer

12

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Mammography: A Contrary View

13

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Breast cancer and other second neoplasms after childhood Hodgkin's disease

14

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Long-term effects of mammography screening: updated overview of the Swedish randomised trials

16

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Analysis of Breast Cancer Mortality and Stage Distribution by Age for the Health Insurance Plan Clinical Trial

19

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

20

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Screening: assessment of current studies

21

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Canadian National Breast Screening Study: assessment of technical quality by external review

24

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

The Canadian National Breast Screening Study: a critical review

27

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study

28

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Statistical power in breast cancer screening trials and mortality reduction among women 40-49 years of age with particular emphasis on the National Breast Screening Study of Canada.

29

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Report of the International Workshop on Screening for Breast Cancer.

30

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Mammographic screening

34

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Clinical strategies for breast cancer screening: weighing and using the evidence

35

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Breast cancer among women in their forties: toward a reasonable research agenda

36

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

May we agree to disagree, or how do we develop guidelines for breast cancer screening in women?

37

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age

38

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Putting the "informed" in informed consent about mammography

39

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Bias in the medical journals: a commentary

40

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Screening mammography in women younger than 50 years of age

42

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Analysis of parenchymal density on mammograms in 1353 women 25-79 years old.

43

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Evidence on screening for breast cancer from a randomized trial

44

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Quantitative Interpretation of Age-Specific Mortality Reductions From the Swedish Breast Cancer-Screening Trials

45

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Breast cancer screening among women in their forties: an overview of the issues

46

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Clinical practice. Mammographic screening for breast cancer

47

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Informed decision making: age of 50 is arbitrary and has no demonstrated influence on breast cancer screening in women

48

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials

49

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Is screening for breast cancer with mammography justifiable?

52

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Cochrane review on screening for breast cancer with mammography.

53

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians

56

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Screening mammography for women age 40 to 49 years

58

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study

59

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

The natural history of invasive breast cancers detected by screening mammography

60

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends

61

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.

62

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Rethinking screening for breast cancer and prostate cancer

63

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

65

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

66

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

The decrease in breast-cancer incidence in 2003 in the United States

67

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement

69

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Evidence-based breast cancer prevention: the importance of individual risk

70

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Screening mammography in women aged 40-49 years: analysis of cost-effectiveness

71

1 reference

10.1016/J.RCL.2010.06.005

https://api.crossref.org/works/10.1016/J.RCL.2010.06.005

19 July 2024

Identifiers

10.1016/J.RCL.2010.06.005

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37792249&oldid=2208339325"